Schizophrenia trials: past, present and future

By C. Adams. 2002

5 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Psychiatry and Mental health, Philosophy

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. Eric B. Laber
2. Daniel J. Lizotte
3. Susan A. Murphy
4. Susan M. Shortreed
5. Joelle Pineau
6. Erica E. Moodie
7. Michael R. Kosorok
8. Chao Yu

In Psychiatry and Mental health

1. Eric B. Laber
2. Susan M. Shortreed
3. Erica E. Moodie
4. Daniel J. Lizotte
5. Susan A. Murphy

In Philosophy

1. Susan M. Shortreed
2. Erica E. Moodie
3. Joelle Pineau

Citations in the corpus

• Informing sequential clinical decision-making through reinforcement learning: an empirical study (2010, background): “In studies of antipsychotics in patients with schizophrenia, dropout is often high, between 30 and 60% (Adams 2002).”
• Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study (2012, background): “Dropout in studies of antipsychotics in patients with schizophrenia is often high: between 30% and 60% (Adams, 2002).”